What Are the Challenges in Targeting Molecular Alterations?
Despite the success of targeted therapies, several challenges remain. Tumor heterogeneity, where different cells within the same tumor harbor distinct genetic alterations, can lead to drug resistance. Additionally, cancer cells may develop secondary mutations that confer resistance to targeted agents. Ongoing research aims to address these challenges by developing combination therapies and identifying new therapeutic targets.
